RSS

drug development

Dr Andrew Rut, CEO and founder of MyMeds&Me, examines the critical role of new technology, in the form of smart pharmaceuticals and blockchain, in advancing patient autonomy and drug development. more

Opinion

NDA Group, European drug development consultancy, has opened a new office in Paris, France, to serve its growing customer base in the country and continue its global expansion. more

A co-founder of the company ApconiX, based in Alderley Park, has revealed his view that attitude towards safety in pre-clinical cancer drug development needs to change. more

Opinion

Health systems are facing the biggest challenge in their existence: financial sustainability fuelled by the costs of prescription drugs. Here, Marisa Miraldo, associate professor at Imperial College Business School, goes into more detail… more

Opinion

Evgen Pharma, a clinical-stage drug development company, has announced its collaboration with King’s College London to advance its lead product candidate as a therapy for ischaemic stroke. more

News

A nonclinical safety company that works with the pharma sector based in Alderley Park, ApconiX, has increased sales by five-fold as a result of the industry’s demand for drug safety expertise. more

News

Gregor Deutschle, global business development manager for SCHOTT, speaks about how small and flexible means fast and profitable in pharma packaging and he reveals what this shift in manufacturing means for the industry and consumers. more

Opinion

Biotechnology acceleration company, Q BioMed, has announced its successful development of a new and proprietary analogue of QBM-001 in partnership with Sphaera Pharma for paediatric nonverbal disorder. more

News

XenoGesis and Juniper Pharma Services have extended their partnership in early drug development services by adding GastroPlus, PBPK modelling and simulation software. more

News

Global health science marketing and communications firm, SCORR Marketing, has released a new study, in partnership with Applied Clinical Trials, evaluating the extent to which collaborations occur in the life sciences what influences them more

Analysis

German biotechnology company, Topas Therapeutics, has signed a multi-year agreement with Eli Lilly and Company, which will see the companies collaborate to generate drug candidates in the field of antigen specific tolerance induction. more

News

A new platform to accelerate drug development has been created through the collaboration of Juniper Pharma Services (a subsidiary of Juniper Pharmaceuticals), and CrystecPharma in the Advanced Manufacturing Supply Chain Initiative (AMSCI). more

Technology

Arsenal Capital Partners has announced it is selling its portfolio company, Certara, to EQT VII Fund for $850 million, although, as a part of the deal, it will retain a minority ownership stake. more

News

Global provider of drug development and delivery solutions to the pharmaceutical sector, Patheon, has revealed it is anticipating to invest approximately $45 million at key sites worldwide to meet growing customer demand more

News

Fewer than two in 10 medicines exceed the average pharmaceutical R&D cost required to bring a drug to market when the risks of failure to reach market approval are factored in, according to GBI Research. more

News

The FDA has granted breakthrough therapy designation to Novartis’ investigational chimeric antigen receptor T cell (CAR-T) therapy, CTL019 more

News

Recently published research from the Massachusetts Institute of Technology (MIT) and Mayo Clinic proposes a mathematical framework that may accelerate drug development. more

News

According to the latest report from GlobalData, pipeline agents in the rheumatoid arthritis space are unlikely to address unmet needs by 2025. more

News

What role will IP management play in protecting pharmaceutical companies in the future? Casey Fowler, VP of IP Search, CPA Global writes. more

News 1 Comments

Anil Kane, Ph.D., MBA, executive director, global head of formulation sciences, pharmaceutical development services at Patheon on finding the right formulation for oral solid dose applications more

News